• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有抗分枝杆菌活性的氨基喹唑啉酮的合成、构效关系及作用机制研究

Synthesis, Structure-Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity.

作者信息

Akester Jessica N, Njaria Paul, Nchinda Aloysius, Le Manach Claire, Myrick Alissa, Singh Vinayak, Lawrence Nina, Njoroge Mathew, Taylor Dale, Moosa Atica, Smith Anthony J, Brooks Elizabeth J, Lenaerts Anne J, Robertson Gregory T, Ioerger Thomas R, Mueller Rudolf, Chibale Kelly

机构信息

Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.

Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.

出版信息

ACS Infect Dis. 2020 Jul 10;6(7):1951-1964. doi: 10.1021/acsinfecdis.0c00252. Epub 2020 Jun 15.

DOI:10.1021/acsinfecdis.0c00252
PMID:32470286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7359024/
Abstract

Phenotypic whole-cell screening against () in glycerol-alanine-salts supplemented with Tween 80 and iron (GASTE-Fe) media led to the identification of a 2-aminoquinazolinone hit compound, sulfone which was optimized for solubility by replacing the sulfone moiety with a sulfoxide . The synthesis and structure-activity relationship (SAR) studies identified several compounds with potent antimycobacterial activity, which were metabolically stable and noncytotoxic. Compound displayed favorable properties and was therefore selected for pharmacokinetic (PK) studies where it was found to be extensively metabolized to the sulfone . Both derivatives exhibited promising PK parameters; however, when was evaluated for efficacy in an acute TB infection mouse model, it was found to be inactive. In order to understand the and discrepancy, compound was subsequently retested using different strains cultured in different media. This revealed that activity was only observed in media containing glycerol and led to the hypothesis that glycerol was not used as a primary carbon source by in the mouse lungs, as has previously been observed. Support for this hypothesis was provided by spontaneous-resistant mutant generation and whole genome sequencing studies, which revealed mutations mapping to glycerol metabolizing genes indicating that the 2-aminoquinazolinones kill via a glycerol-dependent mechanism of action.

摘要

在补充了吐温80和铁的甘油 - 丙氨酸 - 盐(GASTE - Fe)培养基中针对()进行表型全细胞筛选,鉴定出一种2 - 氨基喹唑啉酮命中化合物,砜,通过用亚砜取代砜部分对其溶解度进行了优化。合成及构效关系(SAR)研究确定了几种具有强效抗分枝杆菌活性的化合物,这些化合物代谢稳定且无细胞毒性。化合物表现出良好的(此处原文缺失相关内容)性质,因此被选用于药代动力学(PK)研究,结果发现它被广泛代谢为砜。两种衍生物均表现出有前景的PK参数;然而,当在急性结核病感染小鼠模型中评估其疗效时,发现它没有活性。为了理解这种(此处原文缺失相关内容)和差异,随后使用在不同培养基中培养的不同(此处原文缺失相关内容)菌株对化合物进行重新测试。结果表明,仅在含有甘油的培养基中观察到活性,并由此提出假设,即甘油在小鼠肺部未被(此处原文缺失相关内容)用作主要碳源,正如之前所观察到的那样。自发抗性突变体的产生和全基因组测序研究为这一假设提供了支持,这些研究揭示了映射到甘油代谢基因的突变,表明2 - 氨基喹唑啉酮通过依赖甘油的作用机制杀死(此处原文缺失相关内容)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/9a6c5e0bca00/id0c00252_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/e02fec7f1351/id0c00252_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/4982c107ea1b/id0c00252_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/c28a95302362/id0c00252_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/050ea68e245e/id0c00252_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/de818debabc8/id0c00252_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/b09f7ccaa1c8/id0c00252_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/dd622b535fc5/id0c00252_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/9a6c5e0bca00/id0c00252_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/e02fec7f1351/id0c00252_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/4982c107ea1b/id0c00252_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/c28a95302362/id0c00252_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/050ea68e245e/id0c00252_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/de818debabc8/id0c00252_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/b09f7ccaa1c8/id0c00252_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/dd622b535fc5/id0c00252_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b854/7359024/9a6c5e0bca00/id0c00252_0004.jpg

相似文献

1
Synthesis, Structure-Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity.具有抗分枝杆菌活性的氨基喹唑啉酮的合成、构效关系及作用机制研究
ACS Infect Dis. 2020 Jul 10;6(7):1951-1964. doi: 10.1021/acsinfecdis.0c00252. Epub 2020 Jun 15.
2
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.社论:结核杆菌药物靶点的现状与展望以及基于构效关系的抗结核药物设计
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
3
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
4
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.设计、合成及色胺酮类化合物作为抗结核药物的构效关系研究。
J Nat Prod. 2013 Mar 22;76(3):354-67. doi: 10.1021/np3007167. Epub 2013 Jan 29.
5
Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.鉴定含 2-苄基-2,7-二氮杂螺[3.5]壬烷部分的苯并噻嗪酮类化合物作为新型抗结核药物。
Eur J Med Chem. 2020 Aug 15;200:112409. doi: 10.1016/j.ejmech.2020.112409. Epub 2020 May 19.
6
[Prospects for development of new antituberculous drugs].[新型抗结核药物的发展前景]
Kekkaku. 2002 Aug;77(8):573-84.
7
Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.设计、合成及新型(E)-4-氧代-巴豆酰胺衍生物类化合物作为潜在抗结核药物的生物评价。
Bioorg Med Chem Lett. 2019 Feb 15;29(4):539-543. doi: 10.1016/j.bmcl.2019.01.001. Epub 2019 Jan 3.
8
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.氨基吡唑并[1,5 - a]嘧啶作为结核分枝杆菌的潜在抑制剂:构效关系及吸收、分布、代谢和排泄特性
Bioorg Med Chem. 2015 Nov 15;23(22):7240-50. doi: 10.1016/j.bmc.2015.10.021. Epub 2015 Oct 22.
9
Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.鉴定含肟官能团的苯并噻嗪酮类化合物作为新型抗结核药物。
Eur J Med Chem. 2019 Nov 1;181:111595. doi: 10.1016/j.ejmech.2019.111595. Epub 2019 Aug 6.
10
Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.N-取代2-氨基噻唑衍生物作为抗结核药物的设计、合成及构效关系研究
Eur J Med Chem. 2014 Jan 24;72:26-34. doi: 10.1016/j.ejmech.2013.11.007. Epub 2013 Nov 13.

引用本文的文献

1
Targeting de novo purine biosynthesis for tuberculosis treatment.靶向从头嘌呤生物合成用于结核病治疗。
Nature. 2025 Jun 18. doi: 10.1038/s41586-025-09177-7.
2
Structural and mechanistic study of a novel inhibitor analogue of cytochrome bc:aa.细胞色素bc:aa新型抑制剂类似物的结构与机制研究
NPJ Drug Discov. 2025;2(1):6. doi: 10.1038/s44386-025-00008-3. Epub 2025 Apr 2.
3
4(3)-Quinazolinone: A Natural Scaffold for Drug and Agrochemical Discovery.4(3)-喹唑啉酮:药物与农用化学品研发的天然骨架

本文引用的文献

1
Hit Generation in TB Drug Discovery: From Genome to Granuloma.结核药物发现中的命中生成:从基因组到肉芽肿。
Chem Rev. 2018 Feb 28;118(4):1887-1916. doi: 10.1021/acs.chemrev.7b00602. Epub 2018 Jan 31.
2
Susceptibility of Mycobacterium tuberculosis Cytochrome Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome .结核分枝杆菌细胞色素氧化酶突变体对靶向末端呼吸氧化酶细胞色素的化合物的敏感性。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.01338-17. Print 2017 Oct.
3
Identification and optimization of a new series of anti-tubercular quinazolinones.
Int J Mol Sci. 2025 Mar 10;26(6):2473. doi: 10.3390/ijms26062473.
4
Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408.增强 Spectinamide 抗结核药物的治疗窗口:磷酸前药 3408 的合成、评估和激活。
Bioorg Med Chem Lett. 2024 Nov 1;112:129934. doi: 10.1016/j.bmcl.2024.129934. Epub 2024 Aug 28.
5
DAIKON: A Data Acquisition, Integration, and Knowledge Capture Web Application for Target-Based Drug Discovery.大根:一个用于基于靶点的药物发现的数据采集、整合与知识捕获的网络应用程序。
ACS Pharmacol Transl Sci. 2023 Jun 22;6(7):1043-1051. doi: 10.1021/acsptsci.3c00034. eCollection 2023 Jul 14.
6
Screening Repurposed Antiviral Small Molecules as Antimycobacterial Compounds by a Lux-Based phoP Promoter-Reporter Platform.通过基于Lux的phoP启动子报告平台筛选重新利用的抗病毒小分子作为抗分枝杆菌化合物。
Antibiotics (Basel). 2022 Mar 9;11(3):369. doi: 10.3390/antibiotics11030369.
7
Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones.螺吡喃并嘧啶酮类:一类对结核分枝杆菌有活性且与氟喹诺酮类药物无交叉耐药性的 DNA 拓扑异构酶抑制剂。
Antimicrob Agents Chemother. 2022 Apr 19;66(4):e0219221. doi: 10.1128/aac.02192-21. Epub 2022 Mar 10.
8
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in .1,3-二芳基吡唑酰基磺酰胺类化合物作为潜在的抗结核药物,靶向细胞壁生物合成。
J Med Chem. 2021 Sep 9;64(17):12790-12807. doi: 10.1021/acs.jmedchem.1c00837. Epub 2021 Aug 20.
9
Strategies to Combat Multi-Drug Resistance in Tuberculosis.结核病的多药耐药性防治策略。
Acc Chem Res. 2021 May 18;54(10):2361-2376. doi: 10.1021/acs.accounts.0c00878. Epub 2021 Apr 22.
新型抗结核喹唑啉酮系列的鉴定与优化
Bioorg Med Chem Lett. 2016 Nov 1;26(21):5290-5299. doi: 10.1016/j.bmcl.2016.09.043. Epub 2016 Sep 16.
4
Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.用于结核病药物发现中快速作用机制评估的生物发光报告基因
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6748-6757. doi: 10.1128/AAC.01178-16. Print 2016 Nov.
5
Treatment of Tuberculosis.结核病的治疗
N Engl J Med. 2015 Nov 26;373(22):2149-60. doi: 10.1056/NEJMra1413919.
6
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.3-(二丙基氨基)-5-羟基苯并呋喃[2,3-f]喹唑啉-1(2H)-酮(DPA-HBFQ-1)对乳腺癌细胞的生长和进展起抑制作用。
Eur J Med Chem. 2016 Jan 1;107:275-87. doi: 10.1016/j.ejmech.2015.11.004. Epub 2015 Nov 10.
7
Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies.一些新型6-甲基-3-苯基-4(3H)-喹唑啉酮类似物的合成、抗肿瘤及抗菌活性:计算机模拟研究
J Enzyme Inhib Med Chem. 2016 Oct;31(5):721-35. doi: 10.3109/14756366.2015.1060482. Epub 2015 Jul 10.
8
Metabolomics of Central Carbon Metabolism in Mycobacterium tuberculosis.结核分枝杆菌中心碳代谢的代谢组学研究。
Microbiol Spectr. 2014 Jun;2(3). doi: 10.1128/microbiolspec.MGM2-0026-2013.
9
Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.观点:基于表型筛选的结核病药物研发中的挑战与机遇
Bioorg Med Chem. 2015 Aug 15;23(16):5087-97. doi: 10.1016/j.bmc.2014.12.031. Epub 2014 Dec 24.
10
Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.结核分枝杆菌中细胞色素C氧化酶受抑制时的呼吸灵活性
Antimicrob Agents Chemother. 2014 Nov;58(11):6962-5. doi: 10.1128/AAC.03486-14. Epub 2014 Aug 25.